BOXLIGHT CORP - CLASS A (BOXL)

US1031972086 - Common Stock

0.85  -0.29 (-25.44%)

After market: 0.9399 +0.09 (+10.58%)

Fundamental Rating

2

BOXL gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 31 industry peers in the Technology Hardware, Storage & Peripherals industry. BOXL may be in some trouble as it scores bad on both profitability and health. BOXL is valued expensive and it does not seem to be growing.



2

1. Profitability

1.1 Basic Checks

BOXL had negative earnings in the past year.
BOXL had a positive operating cash flow in the past year.
BOXL had negative earnings in each of the past 5 years.
In multiple years BOXL reported negative operating cash flow during the last 5 years.

1.2 Ratios

With a Return On Assets value of -21.62%, BOXL is not doing good in the industry: 73.33% of the companies in the same industry are doing better.
BOXL's Return On Equity of -87.21% is on the low side compared to the rest of the industry. BOXL is outperformed by 60.00% of its industry peers.
Industry RankSector Rank
ROA -21.62%
ROE -87.21%
ROIC N/A
ROA(3y)-11.78%
ROA(5y)-18.6%
ROE(3y)-37.84%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

Looking at the Gross Margin, with a value of 34.44%, BOXL is in the better half of the industry, outperforming 63.33% of the companies in the same industry.
In the last couple of years the Gross Margin of BOXL has grown nicely.
BOXL does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 34.44%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y25.71%
GM growth 5Y9.25%

2

2. Health

2.1 Basic Checks

BOXL does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, BOXL has more shares outstanding
BOXL has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, BOXL has a worse debt to assets ratio.

2.2 Solvency

BOXL has an Altman-Z score of 0.17. This is a bad value and indicates that BOXL is not financially healthy and even has some risk of bankruptcy.
BOXL's Altman-Z score of 0.17 is on the low side compared to the rest of the industry. BOXL is outperformed by 76.67% of its industry peers.
BOXL has a Debt/Equity ratio of 1.06. This is a high value indicating a heavy dependency on external financing.
BOXL has a worse Debt to Equity ratio (1.06) than 63.33% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.06
Debt/FCF N/A
Altman-Z 0.17
ROIC/WACCN/A
WACC15.59%

2.3 Liquidity

BOXL has a Current Ratio of 2.10. This indicates that BOXL is financially healthy and has no problem in meeting its short term obligations.
BOXL has a Current ratio of 2.10. This is comparable to the rest of the industry: BOXL outperforms 60.00% of its industry peers.
BOXL has a Quick Ratio of 1.08. This is a normal value and indicates that BOXL is financially healthy and should not expect problems in meeting its short term obligations.
With a Quick ratio value of 1.08, BOXL perfoms like the industry average, outperforming 56.67% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.1
Quick Ratio 1.08

3

3. Growth

3.1 Past

BOXL shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -141.73%.
BOXL shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -16.61%.
Measured over the past years, BOXL shows a very strong growth in Revenue. The Revenue has been growing by 36.13% on average per year.
EPS 1Y (TTM)-141.73%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%33.33%
Revenue 1Y (TTM)-16.61%
Revenue growth 3Y47.65%
Revenue growth 5Y36.13%
Sales Q2Q%-26.94%

3.2 Future

BOXL is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 24.16% yearly.
The Revenue is expected to decrease by -6.58% on average over the next years.
EPS Next Y33.2%
EPS Next 2Y24.16%
EPS Next 3Y24.16%
EPS Next 5YN/A
Revenue Next Year-17.5%
Revenue Next 2Y-8.32%
Revenue Next 3Y-6.58%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for BOXL. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for BOXL. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of BOXL is on the same level as its industry peers.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 128.17

4.3 Compensation for Growth

BOXL's earnings are expected to grow with 24.16% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y24.16%
EPS Next 3Y24.16%

0

5. Dividend

5.1 Amount

BOXL does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

BOXLIGHT CORP - CLASS A

NASDAQ:BOXL (1/8/2025, 8:00:01 PM)

After market: 0.9399 +0.09 (+10.58%)

0.85

-0.29 (-25.44%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryTechnology Hardware, Storage & Peripherals
Earnings (Last)11-13 2024-11-13/amc
Earnings (Next)N/A N/A
Inst Owners5.63%
Inst Owner Change0%
Ins Owners3.68%
Ins Owner Change-0.11%
Market Cap8.36M
Analysts80
Price Target1.15 (35.29%)
Short Float %0.87%
Short Ratio0.92
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DP-4.16%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-27.02%
Min EPS beat(2)-104.09%
Max EPS beat(2)50.06%
EPS beat(4)2
Avg EPS beat(4)-56.24%
Min EPS beat(4)-195.68%
Max EPS beat(4)50.06%
EPS beat(8)5
Avg EPS beat(8)-48.8%
EPS beat(12)7
Avg EPS beat(12)-20.99%
EPS beat(16)9
Avg EPS beat(16)-17.49%
Revenue beat(2)0
Avg Revenue beat(2)-13.68%
Min Revenue beat(2)-14.02%
Max Revenue beat(2)-13.35%
Revenue beat(4)2
Avg Revenue beat(4)-4.09%
Min Revenue beat(4)-14.02%
Max Revenue beat(4)6.89%
Revenue beat(8)3
Avg Revenue beat(8)-6.79%
Revenue beat(12)6
Avg Revenue beat(12)-2.71%
Revenue beat(16)9
Avg Revenue beat(16)0.1%
PT rev (1m)-10%
PT rev (3m)-15.62%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-22.67%
EPS NY rev (1m)-43.63%
EPS NY rev (3m)-43.63%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-15.01%
Revenue NY rev (1m)-3.74%
Revenue NY rev (3m)-5.51%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.06
P/FCF N/A
P/OCF 6.67
P/B 0.24
P/tB N/A
EV/EBITDA 128.17
EPS(TTM)-3.07
EYN/A
EPS(NY)-1.3
Fwd EYN/A
FCF(TTM)-0.01
FCFYN/A
OCF(TTM)0.13
OCFY14.98%
SpS15.33
BVpS3.57
TBVpS-0.68
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -21.62%
ROE -87.21%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 34.44%
FCFM N/A
ROA(3y)-11.78%
ROA(5y)-18.6%
ROE(3y)-37.84%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y25.71%
GM growth 5Y9.25%
F-Score3
Asset Turnover1.07
Health
Industry RankSector Rank
Debt/Equity 1.06
Debt/FCF N/A
Debt/EBITDA 129.76
Cap/Depr 16.8%
Cap/Sales 0.91%
Interest Coverage N/A
Cash Conversion 437.76%
Profit Quality N/A
Current Ratio 2.1
Quick Ratio 1.08
Altman-Z 0.17
F-Score3
WACC15.59%
ROIC/WACCN/A
Cap/Depr(3y)10.73%
Cap/Depr(5y)8.51%
Cap/Sales(3y)0.48%
Cap/Sales(5y)0.39%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-141.73%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%33.33%
EPS Next Y33.2%
EPS Next 2Y24.16%
EPS Next 3Y24.16%
EPS Next 5YN/A
Revenue 1Y (TTM)-16.61%
Revenue growth 3Y47.65%
Revenue growth 5Y36.13%
Sales Q2Q%-26.94%
Revenue Next Year-17.5%
Revenue Next 2Y-8.32%
Revenue Next 3Y-6.58%
Revenue Next 5YN/A
EBIT growth 1Y-392.56%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year157.54%
EBIT Next 3Y32.1%
EBIT Next 5YN/A
FCF growth 1Y-101.17%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-88.87%
OCF growth 3YN/A
OCF growth 5YN/A